Avantor (NYSE:AVTR) Cut to “Neutral” at Bank of America

Bank of America cut shares of Avantor (NYSE:AVTR) from a buy rating to a neutral rating in a research report report published on Monday morning, MarketBeat reports. They currently have $13.00 target price on the stock.

Other research analysts have also recently issued research reports about the company. UBS Group set a $12.00 price target on Avantor in a research report on Thursday, October 30th. Evercore ISI dropped their price objective on shares of Avantor from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Thursday, October 30th. Barclays reiterated an “equal weight” rating and set a $12.00 target price (down previously from $15.00) on shares of Avantor in a research report on Thursday, October 30th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $12.00 price target (down previously from $14.00) on shares of Avantor in a research report on Thursday, October 30th. Finally, Robert W. Baird raised their price objective on shares of Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a report on Friday, October 24th. Four research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Avantor currently has a consensus rating of “Hold” and an average target price of $13.97.

Avantor Trading Down 1.1%

Shares of AVTR stock opened at $11.08 on Monday. The company has a 50 day moving average of $12.30 and a 200-day moving average of $12.81. The company has a quick ratio of 0.96, a current ratio of 1.49 and a debt-to-equity ratio of 0.65. Avantor has a 12-month low of $10.62 and a 12-month high of $23.32. The firm has a market cap of $7.55 billion, a P/E ratio of -85.19, a PEG ratio of 3.86 and a beta of 0.93.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $0.22 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.01). Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The firm had revenue of $1.62 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same quarter in the previous year, the company posted $0.26 EPS. Avantor’s revenue for the quarter was down 5.3% on a year-over-year basis. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. Sell-side analysts anticipate that Avantor will post 1.06 earnings per share for the current year.

Insider Activity at Avantor

In other news, Director Gregory L. Summe purchased 100,000 shares of the business’s stock in a transaction on Thursday, October 30th. The stock was purchased at an average cost of $11.25 per share, with a total value of $1,125,000.00. Following the acquisition, the director directly owned 300,000 shares in the company, valued at approximately $3,375,000. This trade represents a 50.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Sanjeev K. Mehra purchased 350,000 shares of the firm’s stock in a transaction dated Friday, December 5th. The stock was purchased at an average cost of $11.09 per share, for a total transaction of $3,881,500.00. Following the acquisition, the director owned 350,000 shares of the company’s stock, valued at approximately $3,881,500. This trade represents a ? increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 1.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Avantor

A number of hedge funds and other institutional investors have recently bought and sold shares of AVTR. Rise Advisors LLC purchased a new stake in shares of Avantor during the 1st quarter valued at $25,000. Northwestern Mutual Wealth Management Co. raised its position in Avantor by 288.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock valued at $28,000 after purchasing an additional 1,263 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC purchased a new position in shares of Avantor in the 2nd quarter worth about $32,000. Finally, FNY Investment Advisers LLC bought a new position in shares of Avantor during the 2nd quarter valued at about $36,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.